A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 143.65
GOOG 905.96
MSFT 68.46
BAC 23.34
FB 150.25

Recently Added

SNAP 22.55
UAA 21.49
LSTR 85.45
UDOW 112.93
DXC 75.34

Gaining Speed

UAA 21.49
SNAP 22.55
LSTR 85.45
UDOW 112.93
TQQQ 95.33

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!